Cargando…

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China

OBJECTIVES: The aim of this study is to describe the reporting rate of adverse events following immunization (AEFI) with pentavalent vaccine: diphtheria-pertussis-tetanus-poliomyelitis-Haemophilus influenzae type b (DPT-IPV/Hib), and to determine whether the reporting rate of AEFI following DPT-IPV/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Xuejiao, Lv, Huakun, Liang, Hui, Wang, Ying, Shen, Linzhi, Chen, Fuxing, Chen, Yaping, Hu, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Licensed Vaccines – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986187/ https://www.ncbi.nlm.nih.gov/pubmed/35108152 http://dx.doi.org/10.1080/21645515.2021.2021711

Ejemplares similares

Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China
por: Hu, Yu, et al.
Publicado: (2022)

A Comparison with Adverse Events Following Immunization Associated with Sabin-Strains and Salk-Strains Inactivated Polio Vaccines in Zhejiang Province, China
por: Lv, Huakun, et al.
Publicado: (2022)

Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China
por: Lv, Huakun, et al.
Publicado: (2022)

Mumps-specific antibody persistence in children aged 3–7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China
por: Sun, Jinfang, et al.
Publicado: (2023)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023)

Measles vaccine uptake and COVID-19
por: Daungsupawong, Hinpetch, et al.
Publicado: (2023)

Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study
por: Zhang, Zhuoyu, et al.
Publicado: (2023)

ASVAC2022 : 8(th) Asian Vaccine Conference
por: Galagoda, Geethani C. S., et al.
Publicado: (2023)

Public health impact of herpes zoster vaccination on older adults in Hong Kong
por: Chan, Paul K. S., et al.
Publicado: (2023)

Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era
por: Ferrari, Cristiana, et al.
Publicado: (2023)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023)

Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis
por: Zhang, Luofei, et al.
Publicado: (2023)

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023)

Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus
por: Hwang, Ji-Young, et al.
Publicado: (2023)

Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review
por: Knuf, Markus, et al.
Publicado: (2023)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
por: George, Marina, et al.
Publicado: (2023)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
por: Li, Dong, et al.
Publicado: (2022)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
por: Lu, Jinmiao, et al.
Publicado: (2022)

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
por: Montalvo Zurbia-Flores, Gerardo, et al.
Publicado: (2021)

Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021
por: Chen, Fuxing, et al.
Publicado: (2022)

Vaccination in preterm and low birth weight infants in India
por: Soans, Santosh, et al.
Publicado: (2021)

Letter to the editor: Correspondence on Chinese medical personnel vaccinations
por: Sekhar, Sejal C., et al.
Publicado: (2022)

Available evidence and potential for vaccines for reduction in antibiotic prescriptions
por: Gabutti, Giovanni
Publicado: (2022)

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
por: Khan, Sadaf, et al.
Publicado: (2021)

Seroprevalence comparison of different varicella vaccines among Turkish children
por: Choi, BongKyoo, et al.
Publicado: (2022)

Burden of vaccine-preventable diseases among at-risk adult populations in the US
por: Kolobova, Irina, et al.
Publicado: (2022)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
por: Agarwal, Anurag, et al.
Publicado: (2022)

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review
por: MacDonald, Shannon E., et al.
Publicado: (2021)

The world’s largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
por: Sahbudak Bal, Zumrut, et al.
Publicado: (2022)

Comparison of varicella outbreaks in schools in China during different vaccination periods
por: Sun, Xiang, et al.
Publicado: (2022)

A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India
por: Reddy, Raghu, et al.
Publicado: (2021)

Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia
por: Islam, Nazmul, et al.
Publicado: (2022)

Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China
por: Yin, Zhiying, et al.
Publicado: (2022)

Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China
por: Wang, Jun, et al.
Publicado: (2022)

Evaluating the impact of universal varicella vaccination among preschool-aged children in Qingdao, China: An interrupted time-series analysis
por: Gao, Zheng, et al.
Publicado: (2022)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

The progress of postapproval clinical studies on Sabin IPV
por: Shi, Li, et al.
Publicado: (2021)

Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?
por: Siegel, Jerry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_adeldqmlq9hcbt4ubs0bfo7nah